Telmisartan Dispersible Tablets Market Is Likely to Experience a Tremendous Growth by 2029

Telmisartan dispersible tablets market is anticipated to grow at a CAGR of 3.2% during the forecast period. Telmisartan dispersible tablets are the type of medications used to treat high blood pressure (hypertension). Telmisartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so blood can flow more easily. The rising incidence of hypertension globally is the major factor accelerating the growth of the global telmisartan dispersible tablets market. In addition, rising expenditure on health, an increase in cardiovascular diseases, and growing tobacco users are fueling the growth of the market.

According to WHO (World Health Organization), more than 1.13 billion people are suffering from hypertension globally, among them, only 1 in each 5 is cured or under control. Among global mortality cases records, hypertension shares 12.8% of all, which means 7.5 billion mortality cases are recorded due to high blood pressure or hypertension. However, the market growth can be hampered by the lack of awareness regarding the use of antihypertensive drugs such as telmisartan dispersible tablets among the population living in rural areas. Apart from these, the introduction of novel drug/therapeutic compounds with disease-modifying capabilities and better effectiveness by major players can bring new growth opportunities to the market during the forecast period.

To Request a Sample of our Report on Telmisartan Dispersible Tablets Market: https://www.omrglobal.com/request-sample/telmisartan-dispersible-tablets-market

Telmisartan Dispersible Tablets Market Segmentation

By Product Type

· 80 mg

· 40 mg

By Distribution Channel

· Online Sales

· Offline Sales

A full Report of Telmisartan Dispersible Tablets Market is Available @ https://www.omrglobal.com/industry-reports/telmisartan-dispersible-tablets-market

Regional Analysis

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Company Profiles

· Abbott Laboratories

· Astellas Pharma Inc.

· Bayer AG

· Beijing Wansheng Pharmaceutical

· Boehringer Ingelheim Ltd.

· Dr. Reddy's Laboratories Ltd

· GSK Plc

· Hema Pharmaceuticals Pvt. Ltd.

· Mylan N.V.

· Novartis AG

· Pfizer, Inc.

· Takeda Pharmaceutical Co. Ltd.

· Teva Pharmaceutical Industries Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/telmisartan-dispersible-tablets-market
https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ec%b5%9c%ec%8b%a0-%ed%8a%b8%eb%a0%8c%eb%93%9c%ec%99%80-%eb%af%b8%eb%9e%98-%eb%b2%94%ec%9c%84%eb%a1%9c-%ec%a0%84-%ec%84%b8%ea%b3%84%ec%a0%81%ec%9c%bc%eb%a1%9c-574/413130/
https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ec%84%b1%ec%9e%a5-%ea%b0%80%ec%86%8d%ed%99%94%eb%a5%bc-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-%ec%97%90%eb%84%88%ec%a7%80-%ea%b0%9c%ec%a1%b0-%ec%8b%9c%ec%9e%a5/48672/
https://monblogapple.com/2023/03/27/la-valeur-marchande-des-produits-dentretien-automobile-devrait-augmenter-dici-2029/
https://revistaeconomiasocial.com/2023/03/27/se-preve-que-el-valor-de-mercado-del-inhibidor-del-receptor-del-factor-de-crecimiento-epidermico-se-expanda-para-2029/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.